Posters Overview
Solute Carrier (SLC) transporter-mediated drug interaction studies are essential in drug development. However, poor solubility and/or non-specific binding issues of highly lipophilic compounds pose significant challenges in in vitro research. Pharmaceutical excipients such as lecithin (PL90) and poloxamer 188 can improve solubility and/or reduce non-specific binding of highly lipophilic compounds. This study aimed to evaluate the effects of PL90 and poloxamer 188 on SLC transporter activities and to establish a good method for assessing transporter-mediated drug interaction studies of highly lipophilic compounds.

Complete the form to view and download this poster.
Stay Connected
Keep up with the latest news and insights.